Evidence map›Paper›PMID 38893596›Full record

ArticleDiagnostics (Basel, Switzerland)2024

MR Relaxometry for Discriminating Malignant Ovarian Cystic Tumors: A Prospective Multicenter Cohort Study.

Naoki Kawahara, Hiroshi Kobayashi, Tomoka Maehana, Kana Iwai, Yuki Yamada, Ryuji Kawaguchi, Junko Takahama, Nagaaki Marugami, Hirotaka Nishi, Yosuke Sakai and 7 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Prediction models for endometriosis-associated ovarian malignancy: A systematic review and meta-analysis.European journal of obstetrics & gynecology and reproductive biology: X · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Naoki KawaharaDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara 634-8522, Japan.ORCID 0000-0003-1154-2481
Hiroshi KobayashiDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara 634-8522, Japan.ORCID 0000-0002-8124-6269
Tomoka MaehanaDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara 634-8522, Japan.ORCID 0009-0001-0598-9466
Kana IwaiDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara 634-8522, Japan.
Yuki YamadaDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara 634-8522, Japan.
Ryuji KawaguchiDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara 634-8522, Japan.
Junko TakahamaDepartment of Radiology, Higashiosaka City Medical Center, Higashiosaka 578-8588, Japan.
Nagaaki MarugamiDepartment of Radiology and Nuclear Medicine, Nara Medical University, Kashihara 634-8522, Japan.
Hirotaka NishiDepartment of Obstetrics and Gynecology, Tokyo Medical University, Shinjuku-Ku, Tokyo 160-0023, Japan.
Yosuke SakaiDepartment of Obstetrics and Gynecology, Tokyo Medical University, Shinjuku-Ku, Tokyo 160-0023, Japan.
Hirokuni TakanoDepartment of Obstetrics and Gynecology, The Jikei University Kashiwa Hospital, Kashiwa 277-8567, Japan.ORCID 0000-0002-6465-7883
Toshiyuki SekiDepartment of Obstetrics and Gynecology, The Jikei University Kashiwa Hospital, Kashiwa 277-8567, Japan.
Kota YokosuDepartment of Obstetrics and Gynecology, The Jikei University Kashiwa Hospital, Kashiwa 277-8567, Japan.
Yukihiro HirataDepartment of Obstetrics and Gynecology, The Jikei University School of Medicine, Minato-Ku, Tokyo 105-8461, Japan.
Koyo YoshidaDepartment of Obstetrics and Gynecology, Juntendo University Urayasu Hospital, Urayasu 279-0021, Japan.
Takafumi UjihiraDepartment of Obstetrics and Gynecology, Juntendo University Urayasu Hospital, Urayasu 279-0021, Japan.
Fuminori KimuraDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara 634-8522, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndometriosis-associated ovarian cancer (EAOC) is a well-known type of cancer that arises from ovarian endometrioma (OE). OE contains iron-rich fluid in its cysts due to repeated hemorrhages in the ovaries. However, distinguishing between benign and malignant tumors can be challenging. We conducted a retrospective study on magnetic resonance (MR) relaxometry of cyst fluid to distinguish EAOC from OE and reported that this method showed good accuracy. The purpose of this study is to evaluate the accuracy of a non-invasive method in re-evaluating pre-surgical diagnosis of malignancy by a prospective multicenter cohort study.

methodsAfter the standard diagnosis process, the R2 values were obtained using a 3T system. Data on the patients were then collected through the Case Report Form (CRF). Between December 2018 and March 2023, six hospitals enrolled 109 patients. Out of these, 81 patients met the criteria required for the study.

resultsThe R2 values calculated using MR relaxometry showed good discriminating ability with a cut-off of 15.74 (sensitivity 80.6%, specificity 75.0%, AUC = 0.750,

conclusionsMR relaxometry has proven to be an effective tool for discriminating EAOC from OE. Regular use of this method is expected to provide significant insights for clinical practice.

Indexed as

endometriosis-associated ovarian cancer (EAOC)magnetic resonance (MR) relaxometryovarian endometrioma (OE)prospective multicenter cohort study

Identifiers

PMID38893596
PMCPMC11172376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.